These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 169311)
41. Cytosine arabinoside and herpes zoster. Juel-Jensen BE Lancet; 1971 Aug; 2(7720):374-5. PubMed ID: 4105070 [No Abstract] [Full Text] [Related]
42. Effect of cytosine arabinoside and two of its analogues on herpes simplex virus type 1 in cell cultures. Matsumoto S; Suganuma T; Ishida N Tohoku J Exp Med; 1974 Dec; 114(4):393-4. PubMed ID: 4376281 [No Abstract] [Full Text] [Related]
43. Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains. Fiala M; Chow A; Guze LB Antimicrob Agents Chemother; 1972 Apr; 1(4):354-7. PubMed ID: 4364937 [TBL] [Abstract][Full Text] [Related]
44. Herpes simplex and zoster. Juel-Jensen BE Br Med J; 1973 Feb; 1(5850):406-10. PubMed ID: 4347938 [No Abstract] [Full Text] [Related]
46. [Herpetic disease]. Sorice F G Mal Infett Parassit; 1971 Jul; 23(7):469-546. PubMed ID: 4334707 [No Abstract] [Full Text] [Related]
47. Effects of cytarabine on virus shedding in herpes simplex virus infections. Juel-Jensen B J Antimicrob Chemother; 1977 Mar; 3 Suppl A():125-9. PubMed ID: 193815 [No Abstract] [Full Text] [Related]
48. Attempt at inhibiting B virus (herpes virus simiae) growth in rabbits by 5-iodo-2'-deoxyuridine. Benda R Acta Virol; 1965 Nov; 9(6):556. PubMed ID: 4379443 [No Abstract] [Full Text] [Related]
49. Selective anti-herpesvirus agents. De Clercq E Antivir Chem Chemother; 2013 Jan; 23(3):93-101. PubMed ID: 23343513 [TBL] [Abstract][Full Text] [Related]
50. [Herpes simplex virus and the nervous system]. Dekker C Ned Tijdschr Geneeskd; 1975 Jun; 119(26):1026-33. PubMed ID: 49029 [No Abstract] [Full Text] [Related]
51. [Influence of various factors on the proliferation of herpes simplex virus. II. With regard to the problem of tolerance of the herpes simplex virus for IDU]. Oshima K Nippon Ganka Gakkai Zasshi; 1967 Aug; 71(8):1211-6. PubMed ID: 4295686 [No Abstract] [Full Text] [Related]
52. Neonatal herpetic infection. Report of two premature infants treated with systemic use of idoxuridine. Tuffi GA; Nahmias AJ Am J Dis Child; 1969 Dec; 118(6):909-14. PubMed ID: 4311014 [No Abstract] [Full Text] [Related]
53. Chemotherapy of virus diseases. Diana GD; Pancic F Angew Chem Int Ed Engl; 1976 Jul; 15(7):410-6. PubMed ID: 182044 [No Abstract] [Full Text] [Related]
54. TUMOR AND VIRUS ANTIGENS OF SIMIAN VIRUS 40: DIFFERENTIAL INHIBITION OF SYNTHESIS BY CYTOSINE ARABINOSIDE. RAPP F; MELNICK JL; KITAHARA T Science; 1965 Feb; 147(3658):625-7. PubMed ID: 14241415 [TBL] [Abstract][Full Text] [Related]
55. [UV inactivation of herpes simplex virus from cell cultures treated with 5-bromodeoxyuridine and 5-iododeoxyuridine]. Schneweis KE Arch Gesamte Virusforsch; 1969; 28(2):203-11. PubMed ID: 4313033 [No Abstract] [Full Text] [Related]
56. Human herpes simplex virus infections. Baringer JR Adv Neurol; 1974; 6():41-51. PubMed ID: 4374880 [No Abstract] [Full Text] [Related]
57. The use of 5-iodo-2'-deoxyuridine (IUDR) in Orabase and plastibase for treatment of oral herpes simplex. Najjar TA; Sleeper HR; Calabresi P J Oral Med; 1969 Apr; 24(2):53-7. PubMed ID: 4308869 [No Abstract] [Full Text] [Related]
59. The effect of cytosine arabinoside on virus production in various cells infected with herpes simplex virus types 1 and 2. Nutter RL; Rapp F Cancer Res; 1973 Jan; 33(1):166-70. PubMed ID: 4345149 [No Abstract] [Full Text] [Related]